TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

CEFEPIME HYDROCHLORIDE
Infectious Disease Approved 2010-05-06
1
Indication
--
Phase 3 Trials
15
Years on Market

Details

Status
Prescription
First Approved
2010-05-06
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: CEFEPIME HYDROCHLORIDE

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Approval History

Loading approval history...

What CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Treats

5 indications

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is approved for 5 conditions since its original approval in 2010. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pneumonia
  • Febrile Neutropenia
  • Urinary Tract Infection
  • Skin and Skin Structure Infections
  • Intra-Abdominal Infections
Source: FDA Label

Drugs Similar to CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
4 shared
QILU ANTIBIOTICS
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +1 more
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
4 shared
SAMSON MEDCL
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +1 more
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
4 shared
Baxter
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +1 more
TYGACIL
TIGECYCLINE
3 shared
PF PRISM CV
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal InfectionsPneumonia
AMPICILLIN AND SULBACTAM
AMPICILLIN SODIUM
2 shared
EUGIA PHARMA SPECLTS
Shared indications:
Skin and Skin Structure InfectionsIntra-Abdominal Infections
AZACTAM
AZTREONAM
2 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract InfectionPneumonia
AZTREONAM
AZTREONAM
2 shared
Pfizer
Shared indications:
Urinary Tract InfectionPneumonia
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
CEFOXITIN SODIUM
2 shared
B BRAUN
Shared indications:
PneumoniaUrinary Tract Infection
CEFOXITIN IN PLASTIC CONTAINER
CEFOXITIN SODIUM
2 shared
SAMSON MEDCL
Shared indications:
PneumoniaUrinary Tract Infection
CEFUROXIME
CEFUROXIME
2 shared
Hikma
Shared indications:
PneumoniaUrinary Tract Infection
CLEOCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
2 shared
Pfizer
Shared indications:
PneumoniaSkin and Skin Structure Infections
DIFLUCAN
FLUCONAZOLE
2 shared
Pfizer
Shared indications:
Urinary Tract InfectionPneumonia
ERTAPENEM SODIUM
ERTAPENEM SODIUM
2 shared
ACS DOBFAR SPA
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure Infections
INVANZ
ERTAPENEM SODIUM
2 shared
Merck
Shared indications:
Intra-Abdominal InfectionsSkin and Skin Structure Infections
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
MEROPENEM
2 shared
B BRAUN MEDICAL
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
PIPERACILLIN
PIPERACILLIN SODIUM
2 shared
ISTITUTO BIO ITA SPA
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
2 shared
B BRAUN MEDICAL
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
TAZICEF
CEFTAZIDIME
2 shared
Pfizer
Shared indications:
PneumoniaUrinary Tract Infection
TIGECYCLINE
TIGECYCLINE
2 shared
Fresenius Kabi
Shared indications:
Skin and Skin Structure InfectionsIntra-abdominal Infections
ZOSYN IN PLASTIC CONTAINER
PIPERACILLIN SODIUM
2 shared
Baxter
Shared indications:
Intra-abdominal InfectionsSkin and Skin Structure Infections
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Cefepime for Injection and Dextrose Injection is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia Empiric therapy for febrile neutropenic patients Uncomplicated and complicated urinary tract infections Uncomplicated skin and skin structure infections Complicated intra-abdominal infections (used in combination with metronidazole) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefepime for Injection and Dextrose Injection and other antibacterial dr...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.